These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32250222)

  • 1. Cancer Stem Cells and Combination Therapies to Eradicate Them.
    Tang Q; Yin D; Wang Y; Du W; Qin Y; Ding A; Li H
    Curr Pharm Des; 2020; 26(17):1994-2008. PubMed ID: 32250222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment.
    Wang T; Narayanaswamy R; Ren H; Torchilin VP
    Cancer Biol Ther; 2016 Jun; 17(6):698-707. PubMed ID: 27259361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells.
    Sun R; Liu Y; Li SY; Shen S; Du XJ; Xu CF; Cao ZT; Bao Y; Zhu YH; Li YP; Yang XZ; Wang J
    Biomaterials; 2015 Jan; 37():405-14. PubMed ID: 25453968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Cancer Stem Cell Targeted Therapy.
    Akbulut H; Babahan C; Abgarmi SA; Ocal M; Besler M
    Crit Rev Oncog; 2019; 24(1):1-20. PubMed ID: 31679215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
    Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
    Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
    Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
    Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting to the source: selective drug targeting of cancer stem cells.
    Ismail F; Winkler DA
    ChemMedChem; 2014 May; 9(5):885-98. PubMed ID: 24760779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
    Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
    J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
    Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
    Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells: targets and potential biomarkers for radiotherapy.
    Krause M; Yaromina A; Eicheler W; Koch U; Baumann M
    Clin Cancer Res; 2011 Dec; 17(23):7224-9. PubMed ID: 21976536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase.
    Patel NJ; Sharon C; Baranwal S; Boothello RS; Desai UR; Patel BB
    Oncotarget; 2016 Dec; 7(51):84608-84622. PubMed ID: 27705927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Stem Cell Metabolism.
    Alvina FB; Gouw AM; Le A
    Adv Exp Med Biol; 2021; 1311():161-172. PubMed ID: 34014542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids.
    Oktem G; Sercan O; Guven U; Uslu R; Uysal A; Goksel G; Ayla S; Bilir A
    Oncol Rep; 2014 Aug; 32(2):641-9. PubMed ID: 24927163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
    El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
    PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
    Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
    Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hide-and-seek: the interplay between cancer stem cells and the immune system.
    Sultan M; Coyle KM; Vidovic D; Thomas ML; Gujar S; Marcato P
    Carcinogenesis; 2017 Feb; 38(2):107-118. PubMed ID: 27866156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.